论文部分内容阅读
促进女性健康是保障公众健康的重要组成部分,同样,保障女性用药安全是保障公众用药安全的必然内容。本文从美国食品药品监督管理局设置的专门保障女性用药安全、促进女性健康的机构—女性健康办公室谈起,简要介绍了其在促进女性健康方面所作的尝试和努力以及取得的一些成果,包括:科学研究项目—整合机构内外的相关资源,以开展科学研究项目的方式,为自身科学决策提供可能;妊娠期研究项目—通过对妊娠期妇女用药及其他相关行为的研究,提高母婴健康;提供合理用药关键信息—开展多种形式的活动,加强合理用药信息的供给和交流等。美国食品药品监督管理局女性健康办公室的这些尝试和努力为我国药品监管部门在相关领域工作的开展和推进提供了有益的经验和借鉴。
To promote women’s health is an important part of ensuring public health. Similarly, ensuring women’s drug safety is an inevitable part of ensuring public safety of medicines. This article starts with the Office of Women’s Health, which is set up by the U.S. Food and Drug Administration to protect the safety of women and promotes feminine health, and briefly introduces its attempts and efforts to promote feminine health and its achievements, including: Scientific research projects - to integrate relevant resources both inside and outside the institution to conduct scientific research projects and to provide for their own scientific decision-making; pregnancy research project - to improve maternal and child health through research on medication and other related behaviors of pregnant women; to provide Rational use of key information - to carry out various forms of activities, to strengthen the supply and exchange of rational drug information. These attempts and efforts by the Office of Feminine Health of the US Food and Drug Administration have provided useful experiences and references for the development and promotion of the work of drug regulatory authorities in related fields in our country.